Riskpilot← Back to searchSign inGet full accessMegapol ApS
APSActiveCVR 40269568Skjulhøj Allé 47Activities of holding companies · NACE 6421Est. 2019— employees
Revenue 2025
DKK -981
EBITDA margin
100.0%
Equity ratio
58.8%
Financial strength
Net profit 2025
DKK 8M
+9591% vs 2024
| Revenue | DKK -981 | — |
| EBITDA | DKK -981 | — |
| Net profit | DKK 8M | +9591% |
| Total assets | DKK 15,2M | +109% |
| Equity | DKK 8,9M | +909% |
| Employees | — | — |
Legal name
Megapol ApS
CVR number
40269568
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
1. februar 2019
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er investering i kapitalandele samt hermed beslægtet virksomhed.
Address
Skjulhøj Allé 47
Email
lll@megapol.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 141 | -65 | -32 | -26 | 0 | — | -1 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 141 | -65 | -32 | -26 | 0 | 0 | -1 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 141 | -65 | -32 | -26 | 0 | 0 | -1 |
| Net financials | 130 | 244 | 1.144 | -367 | -362 | 85 | 8.031 |
| Profit before tax | 271 | 179 | 1.112 | -393 | -362 | 85 | 8.030 |
| Tax | 30 | -12 | 14 | 30 | -5 | 2 | 1 |
| Net profit | 241 | 192 | 1.098 | -423 | -357 | 83 | 8.029 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 3.875 | 4.733 | 7.020 | 7.078 | 7.335 | 7.263 | 15.150 |
| Equity | 291 | 483 | 1.581 | 1.158 | 801 | 884 | 8.912 |
| Long-term debt | 3.400 | 4.164 | 5.324 | 5.879 | 6.512 | 6.352 | 6.225 |
| Short-term debt | 184 | 86 | 115 | 41 | 22 | 27 | 13 |
| Total debt | 3.584 | 4.250 | 5.439 | 5.920 | 6.534 | 6.379 | 6.238 |
EBITDA margin
-98100.0%
This company
15.8%
Market median
-620986% vs market
20192025
Equity ratio
58.8%
This company
38.2%
Market median
+54% vs market
20192025
Return on equity
90.1%
This company
18.4%
Market median
+390% vs market
20192025
Net profit margin
802868000.0%
This company
8.1%
Market median
+9911950517% vs market
20192025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20192025
Debt / equity
0.70×
This company
0.62×
Market median
+13% vs market
20192025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-02-01 – 2019-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Megapol ApS (this company)
CanaDan Bio ApSBoard members of Megapol ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|